Health Dictionary Find a Doctor

Alcoholic hepatitis

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Alcoholic hepatitis is caused be excessive consumption of alcohol. In US, 7.2% of adults suffer from alcohol use disorder. Symptoms of Alcoholic hepatitis may vary from mild to severe; therefore; any suspected patient should undergo liver function test and ultrasound to screen for Alcoholic hepatitis. Alcoholic hepatitis may progress to hepatic steatonecrosis,fibrosis, cirrhosis or hepatocellular carcinoma. Consequently, all patients must be advised for alcohol abstinence. Additionally, nutritional supplements including folic acid, thiamine, vitamin B6, vitamin A and zinc can be provided. If Alcoholic hepatitis progress to cirrhosis, liver transplant will be considered for treatment.

Historical Perspective

Alcoholic hepatitis was first recognized in 1961 after investigation of 7 cases with excessive alcohol intake . Before the recognition of Alcoholic hepatitis, it was believed that the symptoms are caused by malnutrition not due to toxic effects of alcohol. Charles S. Lieber developed modern research on alcohol-related liver disease.

Pathophysiology

The pathophysiology of Alcoholic hepatitis is caused by interplay between alcohol metabolism, inflammation and innate immunity. Alcohol metabolism leads to depletion of NAD and subsequent lipogenesis. Additionally, increased endotoxemia causes translocation of lipopolysaccharide from intestine to hepatocytes. In hepatocytes, lipopolysaccharide activates kupffer cells. Therefore, activated cells release inflammatory markers which lead to Alcoholic hepatitis.

Causes

Alcohol is a significant cause of Alcoholic hepatitis. Other factors that may associate with Alcoholic hepatitis are hepatitis C and malnutrition.

Differentiating Alcoholic Hepatitis from other Diseases

Alcoholic Hepatitis should be differentiated from viral hepatitis, autoimmune hepatitis, non-alcoholic fatty liver disease, drug-induced liver injury, Wilson disease, cholestatic causes of liver disease, and hepatocellular carcinoma.

Epidemiology and Demographics

In US, 7.2% of adults suffer from alcohol use disorder.The peak incidence of Alcoholic hepatitis is between 20-60 years of age.In 2007, Alcoholic hepatitis was accounted for 0.71% of all hospital admissions in US. Women are at greater risk of developing Alcoholic hepatitis after shorter duration and smaller amount of alcohol intake.

Risk Factors

The most commonrisk factors of developing Alcoholic hepatitis include heavy alcohol intake, High body mass index, Female gender , Malnutrition and hepatitis C.

Screening

Patients with excessive alcohol intake requires screening for alcohol use with AUDIT questionnaire. If the score is above 8, Alcohol use disorder is diagnosed and patient requires further evaluation by performing liver test and liver ultrasound.

Natural history, Complications and Prognosis

Alcoholic liver disease may progress to fatty liver, hepaticsteatosis, Alcoholic hepatitis or alcoholic steatonecrosis,fibrosis, cirrhosis and hepatocellular carcinoma. Complications of Alcoholic hepatitis include [[variceal hemorrhage,hepatic encephalopathy,ascites,coagulopathy, thrombocytopenia,spontaneous bacterial peritonitis, and iron overload. Different scoring systems were presented to predict the prognosis and mortality among patients with Alcoholic hepatitis. The most recent and accurate one is called Asymmetric dimethylarginine (ADMA) score.

Diagnosis

History and Symptoms

Alcoholic hepatitis is suspected to occur in patients with excessive drinking over the decades.Symptoms of Alcoholic hepatitis can vary from mild to severe.The symptoms include nausea,malaise, low-grade fever, abdominal Pain, yellow discoloration of skin increased abdominal girth due to ascites, gastrointestinal bleeding due to variceal hemorrhage, lack of appetite, confusion, and lethargy.

Physical Examination

Physical examination findings include fever, tachycardia, tachypnea,respiratory alkalosis,hepatomegaly,hepatic tenderness ,scleral icterus,splenomegaly, ascites,ssterixis, darkening of the urine, peripheral edema,gynecomastia,palmer erythema,Spider angiomas, altered hair distribution, Proximal muscle wasting.

Laboratory Findings

The most frequent laboratory findings of Alcoholic hepatitis include neutrophilic leukocytosis with bandemia,anemia ,AST/ALT ratio greater than 2, mild elevation of Alkaline Phosphatase, hypoalbuminemia, hyperbilirubinemia,prolonged prothrombin time, and elevated gamma-glutamyl transpeptidase level.

X-Ray

There are no x-ray findings associated with Alcoholic hepatitis.

CT

CT scan is usually performed among patients with Alcoholic hepatitis to exclude other abnormalities including neoplasm, biliary obstruction or infiltrative liver disease.CT scan can predict severity and outcome of Alcoholic hepatitis by presence of splenomegaly, ascites, varices, liver length to mid clavicular line, decreased liver attenuation, liver to spleen attenuation ratio and increased liver heterogenecity.

MRI

MRI findings of Alcoholic hepatitis are non-specific is usually done to exclude other etiologies and include hepatic steatosis, increase T2 signal around portal system, and Increased intensity in parenchymal signal.

Ultrasound

Ultrasound is the first choice of imaging test in Alcoholic hepatitis. The finding are hepatomegaly,irregular outline of liver surface and edge nodularity, diffuse hyper-echoic liver,Atrophy of right lobe. Additionally, splenomegaly, varices and [ascites]] are suggestive features of portal hypertension.

Other Diagnostic Studies

Liver biopsy is indicated in patients whose diagnosis is uncertain and in patients with severe Alcoholic hepatitis who are probable to undergo medical treatment. Liver biopsy in Alcoholic Hepatitis include Polymorphonuclear infiltration, hepatic necrosis, Mallory bodies in hepatocytes, perivenular and perisinusoidal fibrosis, ballooning hepatocytes, and steatosis.

Treatment

Medical Therapy

All patients with Alcoholic Hepatitis must be advised to stopped alcohol use. Additionally, nutritional supplements including folic acid, thiamine, vitamin B6, vitamin A and zinc can be provided. Glucocorticoids is the most common pharmacologic treatment in Alcoholic hepatitis .Pentoxifylline can be used in patient with contraindication to steroids.

Surgery

Liver transplant is considered in case of cirrhosis. Orthotopic liver transplant is the definitive surgical treatment for hepatic failure associated with Alcoholic Hepatitis. Prior to liver transplant, 6 months of abstinence is required.

Primary Prevention

The primary prevention of Alcoholic hepatitis is alcohol abstinence.Alcohol abstinence improves histological features of hepatic injury and reduces portal hypertension and the risk of cirrhosis. Risk of recidivism is 67% to 81% after alcohol abstinence; therefore, combination psychotherapy with cognitive behavioral therapy, peer driven support counseling, motivational enhancement therapy, and comprehensive medical care.

Secondary Prevention

Disulfiram, naltrexone, and acamprosate are used to to maintain alcohol abstinence.Additionally, baclofen and gamma hydroxyl butyrate are options to reduce recidivism in patients with advanced chronic liver disease.

References

Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Alcoholic hepatitis was first recognized in 1961 after investigation of 7 cases with excessive alcohol intake . Before the recognition of Alcoholic Hepatitis, it was believed that the symptoms are caused by malnutrition not due to toxic effects of alcohol. Charles S. Lieber developed modern research on alcohol-related liver disease.

Historical Perspective

References

  1. 1.0 1.1 Neuman, M. G.; Cohen, L.; Zakhari, S.; Nanau, R. M.; Mueller, S.; Schneider, M.; Parry, C.; Isip, R.; Seitz, H. K. (2014). “Alcoholic Liver Disease: A Synopsis of the Charles Lieber’s Memorial Symposia 2009-2012”. Alcohol and Alcoholism. 49 (4): 373–380. doi:10.1093/alcalc/agu021. ISSN 0735-0414.
  2. 2.0 2.1 Beckett, A. G.; Livingstone, A. V.; Hill, K. R. (1961). “Acute Alcoholic Hepatitis”. BMJ. 2 (5260): 1113–1119. doi:10.1136/bmj.2.5260.1113. ISSN 0959-8138.

Template:WikiDoc Sources

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]Prashanth Saddala M.B.B.S

Overview

The pathophysiology of Alcoholic Hepatitis is caused by interplay between alcohol metabolism, inflammation and innate immunity. Alcohol metabolism leads to depletion of NAD and subsequent lipogenesis. Additionally, increased endotoxemia causes translocation of lipopolysaccharide from intestine to hepatocytes. In hepatocytes, lipopolysaccharide activates kupffer cells. Therefore, activated cells release inflammatory markers which lead to Alcoholic hepatitis.

Pathophysiology

Pathogenesis

Genetics

Associated Conditions

Conditions associated with alcoholic liver disease include:[2][8]

Microscopic Pathology

On microscopic histopathological analysis characteristic findings of Alcoholic Hepatitis include:

References

  1. 1.0 1.1 1.2 Gao, Bin; Bataller, Ramon (2011). “Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets”. Gastroenterology. 141 (5): 1572–1585. doi:10.1053/j.gastro.2011.09.002. ISSN 0016-5085.
  2. 2.0 2.1 Ceni E, Mello T, Galli A (2014). “Pathogenesis of alcoholic liver disease: role of oxidative metabolism”. World J. Gastroenterol. 20 (47): 17756–72. doi:10.3748/wjg.v20.i47.17756. PMC 4273126. PMID 25548474.
  3. 3.0 3.1 Bautista, Abraham P (2001). “Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease“. Journal of Gastroenterology and Hepatology. 15 (4): 349–356. doi:10.1046/j.1440-1746.2000.02174.x. ISSN 0815-9319.
  4. Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R (2015). “Alcoholic hepatitis: The pivotal role of Kupffer cells”. World J Gastrointest Pathophysiol. 6 (4): 90–8. doi:10.4291/wjgp.v6.i4.90. PMC 4644891. PMID 26600966.
  5. Bird G (1994). “Interleukin-8 in alcoholic liver disease”. Acta Gastroenterol Belg. 57 (3–4): 255–9. PMID 7810274.
  6. Laso FJ, Lapeña P, Madruga JI, San Miguel JF, Orfao A, Iglesias MC; et al. (1997). “Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake”. Alcohol Clin Exp Res. 21 (7): 1226–31. PMID 9347083.
  7. Zintzaras E, Stefanidis I, Santos M, Vidal F (2006). “Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?”. Hepatology. 43 (2): 352–61. doi:10.1002/hep.21023. PMID 16440362.
  8. Lucey, Michael R.; Mathurin, Philippe; Morgan, Timothy R. (2009). “Alcoholic Hepatitis”. New England Journal of Medicine. 360 (26): 2758–2769. doi:10.1056/NEJMra0805786. ISSN 0028-4793.
  9. 9.0 9.1 9.2 Cotran. Robbins Pathologic Basis of Disease. Philadelphia: W.B Saunders Company. 0-7216-7335-X. Unknown parameter |coauthors= ignored (help)

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Alcohol is a significant cause of Alcoholic hepatitis. Other factors that may associate with Alcoholic Hepatitis are hepatitis C and malnutrition.

Causes

References

  1. “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
  2. 2.0 2.1 Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A; et al. (2019). “Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature”. Int J Mol Sci. 20 (2). doi:10.3390/ijms20020395. PMC 6358912. PMID 30658519.

Template:WH Template:WS

Differentiating Alcoholic hepatitis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

Alcoholic Hepatitis should be differentiated from viral hepatitis, autoimmune hepatitis, non-alcoholic fatty liver disease, drug-induced liver injury, Wilson disease, cholestatic causes of liver disease, and cirrhosis.

Differentiating Alcoholic hepatitis from other Diseases

Alcoholic hepatitis can be differentiated from other liver diseases based on the presence of jaundice and other symptoms including fever and abdominal pain.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]

Abbreviations: RUQ= Right upper quadrant of the abdomen, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CT= Computed tomography

Classification of jaundice based on etiology Disease History and clinical manifestations Diagnosis
Lab Findings Other blood tests Other diagnostic
Family history Fever RUQ Pain Pruritis AST ALT ALK BLR Indirect BLR Direct Viral serology
Hepatocellular Jaundice Alcoholic

liver disease

Alcoholic hepatitis -/+ -/+ ↑↑ N ↑/N N
Cirrhosis -/+ -/+ -/+ ↑/N ↑/N ↑/N -/+ Low platelet Small liver on ultrasound
Jaundice Hemochromatosis + -/+ ↑/N ↑/N N Ferritin Liver biopsy
Wilson’s disease + -/+ N ↑/N N Serum cerulloplasmin ↑ Liver biopsy
Viral hepatitis -/+ N ↑/N N + Specific viral antibody for each type
Drug induced hepatitis -/+ N ↑/N N
Autoimmune hepatitis -/+ -/+ N ↑/N N Anti-LKM antibody Liver biopsy
Cholestatic Jaundice Common bile duct stone -/+ + + N N N Dilated ducts on ultrasound CT/ERCP
Hepatitis A cholestatic type -/+ + + N N N + HAV– AB Abdominal ultrasound
EBV / CMV hepatitis -/+ + + N N N + Positive serology
Primary biliary cirrhosis -/+ -/+ + N/↑ N/↑ N AMA positive Liver biopsy
Primary sclerosing cholangitis -/+ -/+ + N/↑ N/↑ N Beading on MRCP Liver biopsy
Pancreatic carcinoma + -/+ N/↑ N/↑ N Mass on ultrasound CT scan for diagnosis

References

  1. Stickel F, Seitz HK (2013). “Update on the management of alcoholic steatohepatitis”. J Gastrointestin Liver Dis. 22 (2): 189–97. PMID 23799218.
  2. Mathurin P, Lucey MR (2012). “Management of alcoholic hepatitis”. J. Hepatol. 56 Suppl 1: S39–45. doi:10.1016/S0168-8278(12)60005-1. PMID 22300464.
  3. Hamberg KJ, Carstensen B, Sørensen TI, Eghøje K (1996). “Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men”. J Clin Epidemiol. 49 (11): 1295–301. PMID 8892498.
  4. Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A (1996). “Cirrhosis and muscle cramps: evidence of a causal relationship”. Hepatology. 23 (2): 264–73. doi:10.1002/hep.510230211. PMID 8591851.
  5. Burra P, Germani G, Masier A, De Martin E, Gambato M, Salonia A, Bo P, Vitale A, Cillo U, Russo FP, Senzolo M (2010). “Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?”. Transplantation. 89 (12): 1425–9. doi:10.1097/TP.0b013e3181e1f1f6. PMID 20463637.
  6. Torruellas C, French SW, Medici V (2014). “Diagnosis of alcoholic liver disease”. World J. Gastroenterol. 20 (33): 11684–99. doi:10.3748/wjg.v20.i33.11684. PMC 4155359. PMID 25206273.
  7. Baraona E, Leo MA, Borowsky SA, Lieber CS (1975). “Alcoholic hepatomegaly: accumulation of protein in the liver”. Science. 190 (4216): 794–5. PMID 1198096.
  8. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). “Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial”. Gastroenterology. 119 (6): 1637–48. PMID 11113085.
  9. Mendenhall CL, Anderson S, Weesner RE, Goldberg SJ, Crolic KA (1984). “Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis”. Am. J. Med. 76 (2): 211–22. PMID 6421159.
  10. Pirovino M, Linder R, Boss C, Köchli HP, Mahler F (1988). “Cutaneous spider nevi in liver cirrhosis: capillary microscopical and hormonal investigations”. Klin. Wochenschr. 66 (7): 298–302. PMID 3131572.
  11. Dutta SK, Dukehart M, Narang A, Latham PS (1989). “Functional and structural changes in parotid glands of alcoholic cirrhotic patients”. Gastroenterology. 96 (2 Pt 1): 510–8. PMID 2910764.
  12. Van Thiel DH, Gavaler JS, Schade RR (1985). “Liver disease and the hypothalamic pituitary gonadal axis”. Semin. Liver Dis. 5 (1): 35–45. doi:10.1055/s-2008-1041756. PMID 3983651.
  13. Epstein O, Dick R, Sherlock S (1981). “Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease”. Gut. 22 (3): 203–6. PMC 1419499. PMID 7227854.
  14. Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L, Etienne JP (1987). “Dupuytren’s contracture, alcohol consumption, and chronic liver disease”. Arch. Intern. Med. 147 (6): 1065–7. PMID 3592873.
  15. Erlinger S, Benhamou J. Cirrhosis: clinical aspects. In: Mcintyre N, Benhamou J, Rizzetto M, editors. Oxford textbook of clinical hepatology. Oxford: University Press; 1991. p. 380.
  16. Groszman R, Franchis R. Portal hypertension. In: Schiff E, Sorrell M, Maddrey W, editors. Diseases of the liver. Philadelphia: Lippincot Williams & Wilkens; 1999. p. 415.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

In US, 7.2% of adults suffer from alcohol use disorder.The peak incidence of Alcoholic Hepatitis is between 20-60 years of age.In 2007, Alcoholic Hepatitis was accounted for 0.71% of all hospital admissions in US. Women are at greater risk of developing Alcoholic Hepatitis after shorter duration and smaller amount of alcohol intake.

Epidemiology and Demographics

Prevalence

  • In US, 7.2% of adults suffer from alcohol use disorder.[1]
  • In Western countries, alcoholis the cause of 80% of hepatotoxic deaths and 50% of liver cirrhosis.[3]
  • According to a survey between 2001-2011 from 211 hospitals, Alcoholic Hepatitis was accounted for 0.08% to 0.09% of hospital admissions.
  • Regarding to another study in 2007, Alcoholic Hepatitis was accounted for 0.71% of all hospital admissions in US.[4]
  • The peak incidence of Alcoholic Hepatitis is between 20-60 years of age.

Gender

References

  1. “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
  2. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH (2018). “ACG Clinical Guideline: Alcoholic Liver Disease”. Am J Gastroenterol. 113 (2): 175–194. doi:10.1038/ajg.2017.469. PMC 6524956 Check |pmc= value (help). PMID 29336434.
  3. Testino G, Leone S, Fagoonee S, Pellicano R (2018). “Alcoholic liver fibrosis: detection and treatment”. Minerva Med. 109 (6): 457–471. doi:10.23736/S0026-4806.18.05844-5. PMID 30221911.
  4. Liangpunsakul S (2011). “Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States”. J Clin Gastroenterol. 45 (8): 714–9. doi:10.1097/MCG.0b013e3181fdef1d. PMC 3135756. PMID 21085006.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

The most commonrisk factors of developing Alcoholic Hepatitis include heavy alcohol intake, High body mass index, Female gender , Malnutrition and hepatitis C.

Risk Factors

References

  1. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF; et al. (1996). “Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study”. Hepatology. 23 (5): 1025–9. doi:10.1002/hep.510230513. PMID 8621128.
  2. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M; et al. (1997). “Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group”. Gut. 41 (6): 845–50. doi:10.1136/gut.41.6.845. PMC 1891602. PMID 9462221.
  3. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC; et al. (2002). “Risk factors of fibrosis in alcohol-induced liver disease”. Hepatology. 35 (3): 635–8. doi:10.1053/jhep.2002.31782. PMID 11870378.
  4. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997). “Excess weight risk factor for alcoholic liver disease”. Hepatology. 25 (1): 108–11. doi:10.1002/hep.510250120. PMID 8985274.
  5. Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O’Brien CP; et al. (2003). “Alcohol potentiates hepatitis C virus replicon expression”. Hepatology. 38 (1): 57–65. doi:10.1053/jhep.2003.50295. PMID 12829987.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Patients with excessive alcohol intake requires screening for alcohol use with AUDIT questionnaire. If the score is above 8, Alcohol use disorder is diagnosed and patient requires further evaluation by performing liver test and liver ultrasound.

Screening

References

  1. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH (2018). “ACG Clinical Guideline: Alcoholic Liver Disease”. Am J Gastroenterol. 113 (2): 175–194. doi:10.1038/ajg.2017.469. PMC 6524956 Check |pmc= value (help). PMID 29336434.

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Alcoholic liver disease may progress to fatty liver, hepaticsteatosis, Alcoholic hepatitis, alcoholic steatonecrosis,fibrosis, cirrhosis and hepatocellular carcinoma. Complications of Alcoholic hepatitis include [[variceal hemorrhage,hepatic encephalopathy,ascites,Coagulopathy, thrombocytopenia,spontaneous bacterial peritonitis, and iron overload. Different scoring systems were presented to predict the prognosis and mortality among patients with Alcoholic hepatitis. The most recent and accurate one is called Asymmetric dimethylarginine (ADMA) score.

Natural history, complication, and prognosis

Natural history

Complication

Prognosis

References

  1. Testino G (2008). “Alcoholic diseases in hepato-gastroenterology: a point of view”. Hepatogastroenterology. 55 (82–83): 371–7. PMID 18613369.
  2. Testino G (2013). “Alcoholic hepatitis”. J Med Life. 6 (2): 161–7. PMC 3725441. PMID 23904876.
  3. “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
  4. Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ (2011). “Treatment of alcoholic liver disease”. Therap Adv Gastroenterol. 4 (1): 63–81. doi:10.1177/1756283X10378925. PMC 3036962. PMID 21317995.
  5. Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C; et al. (2018). “Alcoholic liver disease”. Nat Rev Dis Primers. 4 (1): 16. doi:10.1038/s41572-018-0014-7. PMID 30115921.
  6. Lourens S, Sunjaya DB, Singal A, Liangpunsakul S, Puri P, Sanyal A; et al. (2017). “Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study”. Mayo Clin Proc Innov Qual Outcomes. 1 (1): 37–48. doi:10.1016/j.mayocpiqo.2017.04.004. PMC 6134907. PMID 30225400.
  7. Parker R, Aithal GP, Becker U, Gleeson D, Masson S, Wyatt JI; et al. (2019). “Natural history of histologically proven alcohol-related liver disease: A systematic review”. J Hepatol. 71 (3): 586–593. doi:10.1016/j.jhep.2019.05.020. PMID 31173814.
  8. O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases. Practice Parameters Committee of the American College of Gastroenterology (2010). “Alcoholic liver disease”. Hepatology. 51 (1): 307–28. doi:10.1002/hep.23258. PMID 20034030.
  9. Al Sibae MR, Cappell MS (2011). “Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS”. Dig Dis Sci. 56 (4): 977–87. doi:10.1007/s10620-010-1390-3. PMID 20844956.
  10. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC; et al. (2005). “Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score”. Gut. 54 (8): 1174–9. doi:10.1136/gut.2004.050781. PMC 1774903. PMID 16009691.
  11. Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C; et al. (2007). “Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis”. Hepatology. 45 (1): 62–71. doi:10.1002/hep.21491. PMID 17187433.

Template:WikiDoc Sources

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH